Анализ результатов хирургического лечения рака почки с опухолевым тромбозом нижней полой вены: опыт одного центра

Анализ результатов хирургического лечения рака почки с опухолевым тромбозом нижней полой вены: опыт одного центра

Автор: Гамаюнов С.В., Ашимов Э.А., Киселев Н.М., Каров В.А., Спиридонов М.А., Заречнова Н.В., Загайнов В.Е.

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Опыт работы онкологических учреждений

Статья в выпуске: 5 т.23, 2024 года.

Бесплатный доступ

Цель исследования - анализ непосредственных результатов хирургического лечения рака почки (РП) с опухолевым тромбозом нижней полой вены (ОТНПВ) на базе одного онкологического центра. материал и методы. Ретроспективный анализ данных 25 пациентов, получивших хирургическое лечение по поводу локального и распространенного РП с ОТНПВ с 01.2021 по 12.2022 г. Медиана наблюдения за пациентами составила 21 мес (ДИ 95 % 14,3-33 мес). Больные распределены на группы согласно классификации Mayo по ОТНПВ: I тип - 8, II тип - 8, III тип - 9 пациентов.

Рак почки, тромбоз нижней полой вены, резекция нижней полой вены, хирургическое лечение

Короткий адрес: https://sciup.org/140307926

IDR: 140307926   |   DOI: 10.21294/1814-4861-2024-23-5-93-102

Список литературы Анализ результатов хирургического лечения рака почки с опухолевым тромбозом нижней полой вены: опыт одного центра

  • Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3): 209-49. https://doi.org/10.3322/caac.21660.
  • Padala S.A., Barsouk A., Thandra K.C., Saginala K., Mohammed A., Vakiti A., Rawla P., Barsouk A. Epidemiology of Renal Cell Carcinoma. World J Oncol. 2020; 11(3): 79-87. https://doi.org/10.14740/wjon1279.
  • Tohi Y., Makita N., Suzuki I., Suzuki R., Kubota M., Sugino Y., Inoue K., Kawakita M. En bloc laparoscopic radical nephrectomy with inferior vena cava thrombectomy: A single-institution experi- ence. Int J Urol. 2019; 26(3): 363-8. https://doi.org/10.1111/iju.13873.
  • Powles T., Albiges L., Bex A., Grünwald V., Porta C., Procopio G., Schmidinger M., Suárez C., de Velasco G.; ESMO Guidelines Committee. ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma. Ann Oncol. 2021; 32(12): 1511-9. https://doi.org/10.1016/j.annonc.2021.09.014.
  • Motzer R.J., Jonasch E., Agarwal N., Alva A., Baine M., Beckermann K., Carlo M.I., Choueiri T.K., Costello B.A., Derweesh I.H., Desai A., Ged Y., George S., Gore J.L., Haas N., Hancock S.L., Kapur P., Kyriakopoulos C., Lam E.T., Lara P.N., Lau C., Lewis B., Madoff D.C., Manley B., Michaelson M.D., Mor- tazavi A., Nandagopal L., Plimack E.R., Ponsky L., Ramalingam S., Shuch B., Smith Z.L., Sosman J., Dwyer M.A., Gurski L.A., Motter A. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022; 20(1): 71-90. https://doi.org/10.6004/jnccn.2022.0001.
  • Singer E.A., Rumble R.B., van Veldhuizen P.J. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline Q&A. JCO Oncol Pract. 2023; 19(3): 127-31. https://doi.org/10.1200/OP.22.00660.
  • Mason N.T., Joshi V.B., Adashek J.J., Kim Y., Shah S.S., Schneider A.M., Chadha J., Jim H.S.L., Byrne M.M., Gilbert S.M., Manley B.J., Spiess P.E., Chahoud J. Cost Efectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma. Eur Urol Oncol. 2023; 6(3): 331-8. https://doi.org/10.1016/j.euo.2023.01.011.
  • Wang B.S., Li Y.Z., Fang Y.Y., Zhang S.D., Ma L.L. Imaging predictors for assessment of inferior vena cava wall invasion in patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective study. Chin Med J (Engl). 2020; 133(17): 2078-83. https://doi.org/10.1097/CM9.0000000000000828.
  • Liu Z., Li L., Hong P., Zhu G., Tang S., Zhao X., Zhang Q., Wang G., He W., Zhang H., Xue H., Cui L., Ge H., Jiang J., Zhang S., Cao F., Yan J., Ma F., Liu C., Ma L., Wang S. A Predictive Model for Tumor Invasion of the Inferior Vena Cava Wall Using Multimodal Imaging in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus. Biomed Res Int. 2020. https://doi.org/10.1155/2020/9530618.
  • Yuan S.M. Surgical treatment of renal cell carcinoma with inferior vena cava tumor thrombus. Surg Today. 2022; 52(8): 1125-33. https://doi.org/10.1007/s00595-021-02429-9.
  • Garg H., Psutka S.P., Hakimi A.A., Kim H.L., Mansour A.M., Pruthi D.K., Liss M.A., Wang H., Gaspard C.S., Ramamurthy C., Svatek R.S., Kaushik D. A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A System- atic Review and Meta-Analysis of Perioperative Outcomes. J Urol. 2022; 208(3): 542-60. https://doi.org/10.1097/JU.0000000000002829.
  • Tabbara M.M., Ciancio G. Surgical treatment of renal cell carcinoma with inferior vena cava tumor thrombus. Surg Today. 2023; 53(7): 855-6. https://doi.org/10.1007/s00595-022-02514-7.
  • Berczi A., Flasko T., Szerafn T., Thomas B., Bacso Z., Berczi C. Surgical Management and Outcome of Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus. Urol Int. 2017; 99(3): 267-71. https://doi.org/10.1159/000464108.
  • Liu Z., Zhang Q., Zhao X., Zhu G., Tang S., Hong P., Ge L., Zhang S., Wang G., Tian X., Zhang H., Liu C., Ma L. Inferior vena cava interruption in renal cell carcinoma with tumor thrombus: surgical strategy and perioperative results. BMC Surg. 2021; 21(1): 402. https://doi.org/10.1186/s12893-021-01400-2.
  • Blute M.L., Leibovich B.C., Lohse C.M., Cheville J.C., Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004; 94(1): 33-41. https://doi.org/10.1111/j.1464-410X.2004.04897.x.
  • Kandori S., Kojima T., Nishiyama H. The updated points of TNM classifcation of urological cancers in the 8th edition of AJCC and UICC. Jpn J Clin Oncol. 2019; 49(5): 421-25. https://doi.org/10.1093/jjco/hyz017.
  • Aldin A., Besiroglu B., Adams A., Monsef I., Piechotta V., Tomlinson E., Hornbach C., Dressen N., Goldkuhle M., Maisch P., Dahm P., Heidenreich A., Skoetz N. First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023; 5(5). https://doi.org/10.1002/14651858.CD013798.pub2.
  • Berg A.A. Malignant hypernephroma of the kidney, its clinical course and diagnosis, with a description of the author’s method of radical operative cure. Surg Gynecol Obstet. 1913; 17: 463-71.
  • Martínez-Salamanca J.I., Linares E., González J., Bertini R., Carballido J.A., Chromecki T., Ciancio G., Daneshmand S., Evans C.P., Gontero P., Haferkamp A., Hohenfellner M., Huang W.C., Koppie T.M., Master V.A., Matloob R., McKiernan J.M., Mlynarczyk C.M., Montorsi F., Nguyen H.G., Novara G., Pahernik S., Palou J., Pruthi R.S., Ramaswamy K., Faba O.R., Russo P., Shariat S.F., Spahn M., Terrone C., Tilki D., Vergho D., Wallen E.M., Xylinas E., Zigeuner R., Libertino J.A. Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Curr Urol Rep. 2014; 15(5): 404. https://doi.org/10.1007/s11934-014-0404-7.
  • Haidar G.M., Hicks T.D., El-Sayed H.F., Davies M.G. Treatment options and outcomes for caval thrombectomy and resection for renal cell carcinoma. J Vasc Surg Venous Lymphat Disord. 2017; 5(3): 430-6. https://doi.org/10.1016/j.jvsv.2016.12.011.
  • Horynecka Z., Jabłońska B., Kurek A., Lekstan A., Piaszczyński M., Mrowiec S., Oczkowicz G., Król R. Analysis of surgical outcomes in 102 patients with renal cell carcinoma with venous tumor thrombus: A retrospective observational singlecenter study. Medicine (Baltimore). 2022; 101(40). https://doi.org/10.1097/MD.0000000000030808.
  • Rehman Z.U., Ather M.H., Aziz W. Surgical Interventions for Renal Cell Carcinoma with Thrombus Extending into the Inferior Vena Cava: A Multidisciplinary Approach. Ann Vasc Dis. 2019; 12(1): 55-59. https://doi.org/10.3400/avd.oa.18-00150.
  • Agochukwu N., Shuch B. Clinical management of renal cell carcinoma with venous tumor thrombus. World J Urol. 2014; 32(3): 581-9. https://doi.org/10.1007/s00345-014-1276-7.
  • Rooseno G., Hakim L., Djojodimedjo T. A systematic review and meta-analysis on the efcacy of preoperative renal artery embolization prior to radical nephrectomy for renal cell carcinoma: Is it necessary? Arch Ital Urol Androl. 2023; 95(4). https://doi.org/10.4081/aiua.2023.12018.
  • Subramanian V.S., Stephenson A.J., Goldfarb D.A., Fergany A.F., Novick A.C., Krishnamurthi V. Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology. 2009; 74(1): 154-9. https://doi.org/10.1016/j.urology.2008.12.084.
  • Shanmugasundaram S., Cieslak J.A., Sare A., Chandra V., Shukla P.A., Kumar A. Preoperative embolization of renal cell carcinoma prior to partial nephrectomy: A systematic review and meta-analysis. Clin Imaging. 2021; 76: 205-12. https://doi.org/10.1016/j.clinimag.2021.04.021.
  • Tang G., Chen X., Wang J., He W., Niu Z. Adjuvant instant preoperative renal artery embolization facilitates the radical neph- rectomy and thrombectomy in locally advanced renal cancer with venous thrombus: a retrospective study of 54 cases. World J Surg Oncol. 2020; 18(1): 206. https://doi.org/10.1186/s12957-020-01985-7.
  • Bex A., Mulders P., Jewett M., Wagstaff J., van Thienen J.V., Blank C.U., van Velthoven R., Del Pilar Laguna M., Wood L., van Melick H.H.E., Aarts M.J., Lattouf J.B., Powles T., de Jong I.J., Rottey S., Tombal B., Marreaud S., Collette S., Collette L., Haanen J. Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial. JAMA Oncol. 2019; 5(2): 164-70. https://doi.org/10.1001/jamaoncol.2018.5543. Erratum in: JAMA Oncol. 2019; 5(2): 271. https://doi.org/10.1001/jamaoncol.2019.0117.
  • Tannir N.M., Albigès L., McDermott D.F., Burotto M., Choueiri T.K., Hammers H.J., Barthélémy P., Plimack E.R., Porta C., George S., Donskov F., Atkins M.B., Gurney H., Kollmannsberger C.K., Grimm M.O., Barrios C., Tomita Y., Castellano D., Grünwald V., Rini B.I., Jiang R., Desilva H., Fedorov V., Lee C.W., Motzer R.J. Nivolumab plus ipilimumab versus sunitinib for frst-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efcacy and safety from the phase III CheckMate 214 trial. Ann Oncol. 2024. https://doi.org/10.1016/j.annonc.2024.07.727.
  • Stewart G.D., Welsh S.J., Ursprung S., Gallagher F.A., Jones J.O., Shields J., Smith C.G., Mitchell T.J., Warren A.Y., Bex A., Boleti E., Carruthers J., Eisen T., Fife K., Hamid A., Laird A., Leung S., Malik J., Mendichovszky I.A., Mumtaz F., Oades G., Priest A.N., Riddick A.C.P., Venugopal B., Welsh M., Riddle K., Hopcroft L.E.M.; NAXIVA Trial Group; Jones R.J. A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA). Br J Cancer. 2022; 127(6): 1051-60. https://doi.org/10.1038/s41416-022-01883-7.
  • Abel E.J., Spiess P.E., Margulis V., Master V.A., Mann M., Zargar-Shoshtari K., Borregales L.D., Sexton W.J., Patil D., Matin S.F., Wood C.G., Karam J.A. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus. J Urol. 2017; 198(2): 281-8. https://doi.org/10.1016/j.juro.2017.03.011.
  • Manso M., Pacheco-Figueiredo L., Santos-Silva A., Silva J., Silva C., Cruz F. Renal Cell Carcinoma with Venous Thrombus: Should Surgery Be Ofered When Metastasis Is Present at Diagno- sis? Urol Int. 2018; 101(4): 387-90. https://doi.org/10.1159/000493510.
  • Kirkali Z., V. Poppel H. A critical analysis of surgery for kidney cancer with vena cava invasion. Eur Urol. 2007; 52(3): 658-62. https://doi.org/10.1016/j.eururo.2007.05.009.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp